Exemption IDE approval

Related by string. * Exemptions . EXEMPTION . exemptions . EXEMPTIONS : Investigational Device Exemption IDE . applicable exemption therefrom . sponsor exemption . Homestead Exemption / Ides . IDEs . ides : Wendy Ide . Java IDE . Actel Libero IDE / ap proval . Approvals . APPROVAL : obtaining regulatory approvals . necessary regulatory approvals . customary regulatory approvals * *

Related by context. Frequent words. (Click for all words.) 64 Completes Enrollment 62 Investigational Device Exemption IDE 62 Pivotal Phase III 62 Investigational Device Exemption 61 FDA Accepts 61 Receives FDA Clearance 61 Presents Positive 61 Pivotal Trial 61 Phase III Clinical Trial 60 FDA Clears 59 Receives CE 59 Clinical Trial Application 58 Initiate Phase 58 Patient Enrollment 58 CryoSeal FS System 57 Bone Graft 57 Transcept Pharmaceuticals 57 Initiates Phase 57 FDA Clearance 57 Files Shelf Registration Statement 57 II Clinical Trial 56 k Clearance 56 Humanitarian Device Exemption 56 Clinical Trial Results 56 Ixempra 56 Application MAA 56 Market Approval PMA 56 multicenter Phase 55 subcutaneous formulation 55 Pivotal Phase 55 Company Nasdaq PRGO 55 FDA approvable letter 55 Clinical Study 55 Generic Version 55 Clinical Trial 54 Combidex 54 REVLIMID lenalidomide 54 Patent Covering 54 OTCQX RHHBY 54 FDA Approves 54 drug eluting coronary stent 54 Phase III Trial 54 Full Prescribing Information 54 phase IIb clinical 54 phase IIa clinical 54 Augment Bone Graft 54 FDA Approval 54 Phase Ib clinical 54 Application BLA 54 CE Marked 53 Study Demonstrates 53 Positive Opinion 53 application sNDA 53 Metastatic Melanoma 53 Telavancin 53 Orphan Drug designation 53 Preclinical Data 53 NeutroSpec 53 Recombinant Human 53 Acute Myocardial Infarction 52 Announces Presentation 52 Exclusive License 52 Phase IIIb 52 Pulmonary Arterial Hypertension 52 Surgical Adhesive 52 submitted Biologics License 52 Marketing Authorization Application 52 Phase 2a clinical 52 Cardiac Resynchronization Therapy 52 FDA Orphan Drug 52 Fast Track Designation 52 received CE Marking 52 pseudobulbar affect PBA 52 VALSTAR 52 Complete Response 52 Acute Coronary Syndromes 52 Phase 2b clinical 52 clinical trial 52 Patent Issued 51 BrachySil 51 Small Molecule 51 Clinical Trials Update 51 injectable formulation 51 carotid stent 51 Celsion Corporation 51 investigational 51 FDA Warns 51 Orphan Drug status 51 Act PDUFA date 51 phase IIa 51 PMA submission 51 Phase IIB 51 Complete Response letter 51 Swissmedic 51 Blood Thinner 51 supplemental Biologics License Application 51 PRISTIQ 51 Response Biomedical Corporation 51 Phase IIa trial 51 orphan designation 51 Approvable Letter

Back to home page